AU6272596A - Synthetic catalytic free radical scavengers useful as antiox idants for prevention and therapy of disease - Google Patents

Synthetic catalytic free radical scavengers useful as antiox idants for prevention and therapy of disease

Info

Publication number
AU6272596A
AU6272596A AU62725/96A AU6272596A AU6272596A AU 6272596 A AU6272596 A AU 6272596A AU 62725/96 A AU62725/96 A AU 62725/96A AU 6272596 A AU6272596 A AU 6272596A AU 6272596 A AU6272596 A AU 6272596A
Authority
AU
Australia
Prior art keywords
idants
antiox
therapy
disease
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62725/96A
Other languages
English (en)
Inventor
Susan Robin Doctrow
Bernard Malfroy-Camine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eukarion Inc
Original Assignee
Eukarion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eukarion Inc filed Critical Eukarion Inc
Publication of AU6272596A publication Critical patent/AU6272596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU62725/96A 1995-06-07 1996-06-06 Synthetic catalytic free radical scavengers useful as antiox idants for prevention and therapy of disease Abandoned AU6272596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/485,489 US5696109A (en) 1992-12-07 1995-06-07 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US485489 1995-06-07
PCT/US1996/010037 WO1996040148A1 (en) 1995-06-07 1996-06-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Publications (1)

Publication Number Publication Date
AU6272596A true AU6272596A (en) 1996-12-30

Family

ID=23928377

Family Applications (2)

Application Number Title Priority Date Filing Date
AU62725/96A Abandoned AU6272596A (en) 1995-06-07 1996-06-06 Synthetic catalytic free radical scavengers useful as antiox idants for prevention and therapy of disease
AU63328/96A Ceased AU719450B2 (en) 1995-06-07 1996-06-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU63328/96A Ceased AU719450B2 (en) 1995-06-07 1996-06-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Country Status (6)

Country Link
US (6) US5696109A (https=)
EP (1) EP0831836A4 (https=)
JP (1) JP4160115B2 (https=)
AU (2) AU6272596A (https=)
CA (1) CA2223510C (https=)
WO (2) WO1996040148A1 (https=)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696109A (en) * 1992-12-07 1997-12-09 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US7582786B2 (en) * 1992-12-07 2009-09-01 Eukarion Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6369106B1 (en) * 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
US6013623A (en) * 1997-02-27 2000-01-11 The Trustees Of Columbia University In The City Of New York Use of heme-peptides to prevent or retard disease associated with oxidative stress
US6214817B1 (en) 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
IL135949A0 (en) 1997-11-03 2001-05-20 Univ Duke Substituted porphyrins
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
TW408203B (en) * 1998-04-06 2000-10-11 Ciba Sc Holding Ag Process for treating textile materials and the relevant compounds
AU766988B2 (en) 1998-04-21 2003-10-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cannabinoids as antioxidants and neuroprotectants
AU771259B2 (en) 1998-04-24 2004-03-18 Aeolus Sciences, Inc. Substituted porphyrins
US6262019B1 (en) 1998-04-30 2001-07-17 Vit-Immune, L. C. Method of treatment of glutathione deficient mammals
GB9817845D0 (en) 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
DK1616869T3 (da) 1999-01-25 2012-05-07 Nat Jewish Health Substituerede porphyriner og deres terapeutiske anvendelse
US6689733B1 (en) 1999-03-08 2004-02-10 Ciba Specialty Chemicals Corporation Manganese complexes of salen ligands and the use thereof
US20040110722A1 (en) * 1999-05-27 2004-06-10 Ornberg Richard L. Modified hyaluronic acid polymers
DE60018925T2 (de) * 1999-05-27 2006-04-13 Pharmacia Corp.(N.D.Ges.D.Staates Delaware) Biomaterialien, modifiziert mit superoxid-dismutase imitatoren
AUPQ180499A0 (en) 1999-07-23 1999-08-19 Biomolecular Research Institute Limited Beta-amyloid peptide inhibitors
US6179804B1 (en) * 1999-08-18 2001-01-30 Oxypatch, Llc Treatment apparatus for wounds
AU2001278864A1 (en) * 2000-06-30 2002-01-30 University Of Cincinnati Peptides with antioxidant and antimicrobial properties
KR100386552B1 (ko) * 2000-08-03 2003-06-02 한국화인케미칼주식회사 올레핀의 비대칭 에폭시화 반응에 유용한 고분자 키랄살렌 유도체
US6589948B1 (en) * 2000-11-28 2003-07-08 Eukarion, Inc. Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
US20020072512A1 (en) * 2000-12-08 2002-06-13 Metaphore Pharmaceuticals, Inc Method of preventing and treating HIV-mediated central nervous system damage
DE60235955D1 (de) * 2001-01-05 2010-05-27 Metaphore Pharmaceuticals Inc Zusammensetzungen und verfahren zur erhöhung der zytokin-aktivität und zur behandlung der hypotension assoziiert mit der verabreichung von zytokinen
EP1392328B1 (en) 2001-01-19 2009-08-12 National Jewish Medical and Research Center Medicament for protection in radiotherapy
WO2002058686A2 (en) * 2001-01-26 2002-08-01 Metaphore Pharmaceuticals, Inc. Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
US20020150582A1 (en) * 2001-02-08 2002-10-17 Friedrichs Gregory S. Method of treating or inhibiting cellular injury or cell death
AU2002312194B8 (en) 2001-06-01 2008-05-15 Aeolus Sciences, Inc. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
CA2449631A1 (en) * 2001-06-08 2002-12-19 Metaphore Pharmaceuticals, Inc. Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
AU784852B2 (en) * 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
US20040132706A1 (en) * 2001-10-05 2004-07-08 Daniela Salvemini Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
JP2005526778A (ja) * 2002-03-15 2005-09-08 アストラル，インコーポレイテッド 免疫調節性非コードｒｎａモチーフを用いて抗体及び主要組織適合性クラスｉ拘束性又はクラスｉｉ拘束性ｔ細胞の応答を開始或いは増強させるための組成物及び方法
US20070037769A1 (en) * 2003-03-14 2007-02-15 Multicell Immunotherapeutics, Inc. Compositions and methods to treat and control tumors by loading antigen presenting cells
EP2258712A3 (en) 2002-03-15 2011-05-04 Multicell Immunotherapeutics, Inc. Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
AU2003237500A1 (en) * 2002-06-07 2003-12-22 Duke University Substituted porphyrins
US6835387B2 (en) 2002-06-11 2004-12-28 Scimed Life Systems, Inc. Sustained release of superoxide dismutase mimics from implantable or insertable medical devices
US20040101521A1 (en) * 2002-07-12 2004-05-27 The Buck Institute For Research On Aging Iron sequestration or elimination to reduce neurodegeneration or Parkinsons disease progression
US20060211628A1 (en) * 2002-08-02 2006-09-21 Daphne Atlas Treatment of multiple sclerosis with brain targeted anti oxidant compounds
US20040132789A1 (en) * 2002-08-22 2004-07-08 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
MXPA05005937A (es) * 2002-12-06 2005-08-18 Alcon Inc Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
US6964365B2 (en) * 2003-05-07 2005-11-15 Mt Pleasant Gregory Library card holder
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
ITTO20040124A1 (it) * 2004-03-01 2004-06-01 Medestea Internaz Srl Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerative
FR2875500A1 (fr) * 2004-09-21 2006-03-24 Centre Nat Rech Scient Complexe chiraux macrocycliques utilisables comme catalyseurs
EP1809272A4 (en) * 2004-10-18 2008-01-02 Maroon Biotech Corp METHOD AND COMPOSITIONS FOR TREATING DAMAGES THROUGH FREE RADICALS
US9044462B2 (en) 2004-12-08 2015-06-02 Avent, Inc. Method for oxygen treatment of intact skin
US20060121101A1 (en) * 2004-12-08 2006-06-08 Ladizinsky Daniel A Method for oxygen treatment of intact skin
US20090234011A1 (en) * 2005-04-21 2009-09-17 Goldstein Glenn A N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress
US8993627B2 (en) 2005-04-21 2015-03-31 Sentient Lifesciences, Inc. N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
US20090258330A1 (en) * 2005-11-18 2009-10-15 Apexum Ltd. Method of Treating Dental Periapical Lesions
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
GB0607096D0 (en) * 2006-04-07 2006-05-17 Imp Innovations Ltd Compound
EP2345974B1 (en) 2006-06-28 2014-08-06 IHI Corporation Magnetically guidable compound
US7724491B2 (en) * 2006-09-14 2010-05-25 Earth Fx, Inc. Method of treating inflammation and autoimmune diseases
US8735154B2 (en) 2006-10-30 2014-05-27 The University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
WO2008070557A2 (en) * 2006-12-01 2008-06-12 Women & Infants Hospital Organometallic complexes as therapeutic agents
EP1949899A1 (en) * 2007-01-23 2008-07-30 Freie Universität Berlin Metal salophen complexes use in prevention and treatment of cancer
JP4753922B2 (ja) * 2007-09-27 2011-08-24 肇 小座野 化粧料用原料
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
JP2009274962A (ja) * 2008-05-12 2009-11-26 Yoshihiro Ishikawa 鉄サレン錯体、磁性を有する薬剤、薬剤の誘導システム、並びに磁気検出装置
US11382895B2 (en) 2008-05-23 2022-07-12 National Jewish Health Methods for treating injury associated with exposure to an alkylating species
US20100098768A1 (en) * 2008-10-16 2010-04-22 Clarkson University Method of neuroprotection from oxidant injury using metal oxide nanoparticles
JP5513405B2 (ja) * 2008-11-20 2014-06-04 株式会社Ｉｈｉ 自己磁性金属サレン錯体化合物
KR101050273B1 (ko) 2008-11-21 2011-07-19 세종대학교산학협력단 살렌 전이금속 착화합물, 및 그 제조 방법
WO2010082092A1 (en) * 2009-01-13 2010-07-22 Claris Lifesciences Limited Propofol based anesthetic with preservative
AU2010290795B2 (en) * 2009-09-04 2015-12-10 Munisekhar Medasani Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
US8933118B2 (en) * 2010-04-28 2015-01-13 Ihi Corporation Anti-brain-tumor drug
JP5873656B2 (ja) * 2011-06-13 2016-03-01 株式会社Ihi 金属サレン錯体化合物、局所麻酔薬剤及び抗悪性腫瘍薬剤
KR102024510B1 (ko) 2011-07-18 2019-11-14 사우디 아람코 테크놀로지스 컴퍼니 금속 착체
EP3498300A1 (en) 2011-07-27 2019-06-19 University of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
JP6046338B2 (ja) * 2011-10-27 2016-12-14 株式会社Ihi ラジカル抑制剤
ES2615260T3 (es) 2011-10-28 2017-06-06 The Chemours Company Tt, Llc Pigmentos inorgánicos que tienen una capacidad de dispersión mejorada y su uso en composiciones de revestimiento
JP5881840B2 (ja) * 2011-10-28 2016-03-09 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ 分散性の改善された処理済み無機顔料およびその紙製品における使用
EP2771409B1 (en) 2011-10-28 2016-12-14 The Chemours Company TT, LLC Treated inorganic core particles having improved dispersability
EP2888271B1 (en) 2012-08-24 2019-11-06 Saudi Aramco Technologies Company Metal complexes
CZ304883B6 (cs) * 2013-06-10 2014-12-29 Univerzita PalackĂ©ho Salophenové komplexy železa s heterocyklickými N-donorovými ligandy, způsob jejich přípravy a jejich použití jako léčiv v protinádorové terapii
US11229382B2 (en) 2013-12-31 2022-01-25 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
JP5806356B2 (ja) * 2014-03-10 2015-11-10 株式会社Ihi 鉄サレン錯体、磁性を有する薬剤、薬剤の誘導システム、並びに磁気検出装置
WO2016197089A1 (en) * 2015-06-05 2016-12-08 Goldstein Glenn A Use of n-acetylcysteine amide in the treatment of acetaminophen overdose
US11154619B2 (en) 2017-02-17 2021-10-26 Creighton University Liposomal compositions with light illumination-induced drug release
CN113061259B (zh) * 2021-03-14 2022-03-29 华中科技大学同济医学院附属协和医院 用于缺血性脑卒中治疗的金属有机框架材料的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106841A (en) * 1986-05-13 1992-04-21 Chai-Tech Corporation Antiviral compositions and method for their use
US5223538A (en) * 1987-03-31 1993-06-29 Duke University Superoxide dismutase mimic
AU678139B2 (en) * 1991-08-26 1997-05-22 Research Corporation Technologies, Inc. Method of enantio selectively epoxidizing cinnamate derivatives
US5696109A (en) * 1992-12-07 1997-12-09 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Also Published As

Publication number Publication date
CA2223510C (en) 2008-05-20
WO1996040149A1 (en) 1996-12-19
US20090311230A1 (en) 2009-12-17
EP0831836A1 (en) 1998-04-01
US20030216371A1 (en) 2003-11-20
US6573257B2 (en) 2003-06-03
WO1996040148A1 (en) 1996-12-19
US5696109A (en) 1997-12-09
US6046188A (en) 2000-04-04
US6900198B2 (en) 2005-05-31
CA2223510A1 (en) 1996-12-19
JP4160115B2 (ja) 2008-10-01
AU6332896A (en) 1996-12-30
AU719450B2 (en) 2000-05-11
US20050249796A1 (en) 2005-11-10
JPH11507646A (ja) 1999-07-06
US20020002157A1 (en) 2002-01-03
EP0831836A4 (en) 2000-09-27

Similar Documents

Publication Publication Date Title
AU6272596A (en) Synthetic catalytic free radical scavengers useful as antiox idants for prevention and therapy of disease
AU4597596A (en) Prevention of protein aggregation
AU7419096A (en) Treatment of vegetables
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
AU6709596A (en) Amide compounds and use of the same
AU6860596A (en) Absorbent products
EP0825867A4 (en) N, O-CARBOXYMETHYLCHITOSAN FOR THE PREVENTION OF SURGICAL ADHESIONS
AU7772794A (en) Treatment of obesity
PL324924A1 (en) Application of at least one betandrenergic atagoniost as that of p substances
AU2180097A (en) Composition for prevention and treatment of periodontal diseases
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
PL325552A1 (en) Derivatives of diaryl alkenylamine
AU6296194A (en) Prevention of unwanted fire
AU7141196A (en) Articles of bedding
SG44055A1 (en) Polymerization of alpha-olefins
AU5699396A (en) Compositions for the treatment of skin conditions
AUPN727595A0 (en) Therapeutic compositions
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU1288295A (en) Preparation of modified vinyl polymers
AU7161096A (en) Compositions and methods for inhibiting the binding of pecam
AU6171196A (en) Therapeutic uses of ta99
AU7210796A (en) Absorbent products
AUPN498095A0 (en) Compounds and compositions
ZA963825B (en) Composition of matter
AU1864195A (en) Prevention of diabetes